Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 10061-10070 of 11953

Edit search filters
  1. A Study to Evaluate the Correlation Between Aging and Bleeding in von Willebrand disease

    Rochester, MN

  2. A Study to Assess Physical Activity Among Hematopoietic Cell Transplant Recipients and Their Caregivers

    Scottsdale/Phoenix, AZ

  3. Survey of Perioperative Experience of Patients Who Have Undergone Gender Affirmation Surgery

    Rochester, MN

  4. A Study to Analyze Gut Microbiota Dysbiosis and Asthma Severity

    Rochester, MN

  5. A Study to Assess Emotional Experiences in Patients with Symptomatic Heart Failure and Left Ventricular Assist Devices

    Rochester, MN

  6. A Study to Evaluate the Impact of a Pharmacist-led Oral Anticancer Medication (OAM) Program on Patient Outcomes

    La Crosse, WI

  7. Noninvasive Measurement of Central Venous Pressure in the Critically Ill

    Rochester, MN

  8. A Study to Obtain Blood from Patients with Gammopathies

    Rochester, MN

  9. Understanding the Prescribing and Adherence to sglt2i Medications by Patients With Ckd

    Rochester, MN

  10. Novel Wearable’s Physiologic Data Inform Real-time On-duty Firefighter Cardiovascular Risk Assessment Guiding Future Strategies For Earlier Interventions To Lower Adverse Cardiovascular Outcome

    Jacksonville, FL

.

Mayo Clinic Footer